Inadequate anticoagulant treatment for stroke prevention in atrial fibrillationApr. 1, 2016 - VBWG Meeting at ACC 2016, Chicago, IL, USA - Christian T. Ruff, MD - Brigham and Women's Hospital, Boston, MA, USA
Despite the availability of effective and safer novel oral anticoagulants (NOACs), as compared with vitamin K antagonists, many high risk patients with atrial fibrillation receive inadequate anticoagulation for stroke prevention. Still too much aspirin is used, which is not effective at preventing stroke.
Vascular Biology Working Group Meeting at ACC 2016, Chicago, IL, USA
Christian T. Ruff, MD - Brigham and Women's Hospital, Boston, MA, USA